Shattuck Labs aims to raise $103M; Beijing biotech gets $55M in Series Dnews2025-08-05T14:35:52+00:00August 5th, 2025|Endpoints News|
Thermo Fisher to lay off 85 workers in San Diego County; Lepu Biopharma inks a dealnews2025-08-04T14:35:10+00:00August 4th, 2025|Endpoints News|
United Therapeutics’ $1B share buyback; Layoffs at a Roivant subsidiarynews2025-08-01T13:49:10+00:00August 1st, 2025|Endpoints News|
Prime Medicine is selling $125M in stock; Nuvectis stops work on ovarian cancer drugnews2025-07-31T14:46:10+00:00July 31st, 2025|Endpoints News|
Merck to discontinue drug from Pandion deal; Coya’s IND for ALS drug is delayednews2025-07-30T14:44:27+00:00July 30th, 2025|Endpoints News|
Bausch Health to buy Durect for $63M upfront; Fulcrum’s Ph1b sickle cell datanews2025-07-29T14:58:21+00:00July 29th, 2025|Endpoints News|
Sarepta pays out $100M milestone to Arrowhead; Boehringer signs up to $1B dealnews2025-07-28T15:28:02+00:00July 28th, 2025|Endpoints News|
Everest Medicines raises $200M; Epirium Bio targets $55M Series Bnews2025-07-25T14:42:58+00:00July 25th, 2025|Endpoints News|
LEO Pharma’s eczema cream is approved in the US; Abivax’s $650M offeringnews2025-07-24T15:11:56+00:00July 24th, 2025|Endpoints News|
Arrowhead’s multibillion-dollar deal with Sarepta is still in place; Pharvaris’ $175Mnews2025-07-23T14:45:42+00:00July 23rd, 2025|Endpoints News|
